Product Details
| Product Name: ORITAVANCIN | CAS No.: 171099-57-3 |
| Min. Order: 1kg | Purity: 99% |
| Supply Ability: 2000ton | Release date: 2024/04/12 |
| Appearance: White crystalline powder |
ORITAVANCIN is the first and only single dose regimen approved by the FDA for the treatment of ABSSSIs. The patient received only one Orbactiv infusion and the entire regimen was over. The approval of Orbactiv also represents a significant advance in the treatment of bacterial skin and skin structure infections that goes well beyond current clinical standards. The FDA has approved the antibiotic Orbactiv (oritavancin, Orivin, IV) injection for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSIs) caused by sensitive Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA).
Storage Condition | Keep in a cool and dry place |
Transportation | By Sea or by Air(DHL/UPS/TNT/FEDEX/EMS) |
Delivery Time | 7-28 days |
Payment | T/T, Western Union or Bitcoin |
Company Profile Introduction
You may like
-
CAS:873857-62-6
-
CAS:1264-72-8
-
CAS:102783-62-0
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-06-26 | ||
| $192.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-04-21 | |
| $5.00 |
Wuhan JiyunZen Tech Co., Ltd.
|
2026-04-10 | ||
| $79.00 |
Hebei Zhuanglai Chemical Trading Co Ltd
|
2025-05-23 | ||
| $12.00 |
Qiuxian Baitai New Material Co., LTD
|
2021-11-23 | ||
| $20.00 |
Longyan Tianhua Biological Technology Co., Ltd
|
2020-11-16 | ||
| $7.00 |
VIP8Y
|
Career Henan Chemical Co
|
2019-07-06 | |
| $7.00 |
VIP8Y
|
Career Henan Chemical Co
|
2019-07-06 |
China- Since: 2020-08-05
- Address: 804, Unit 2, Building 4, i City, No. 11, South Tangyan Road, High-tech Zone, Xi 'an, Shaanxi